Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16898 http://scihub22266oqcxt.onion/10.1111/bjh.16898 32480420!7300844!32480420     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Haematol 2020 ; 190 (3): 346-357 Nephropedia Template TP {{tp|p=32480420|t=2020. Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic |pdf=|usr=}}{{32480420}} gab.com Text Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32480420 #FOAvip The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated coronavirus disease 2019 (COVID-19) is primarily manifested as a respiratory tract infection, but may affect and cause complications in multiple organ systems (cardiovascular, gastrointestinal, kidneys, haematopoietic and immune systems), while no proven specific therapy exists. The challenges associated with COVID-19 are even greater for patients with light chain (AL) amyloidosis, a rare multisystemic disease affecting the heart, kidneys, liver, gastrointestinal and nervous system. Patients with AL amyloidosis may need to receive chemotherapy, which probably increases infection risk. Management of COVID-19 may be particularly challenging in patients with AL amyloidosis, who often present with cardiac dysfunction, nephrotic syndrome, neuropathy, low blood pressure and gastrointestinal symptoms. In addition, patients with AL amyloidosis may be more susceptible to toxicities of drugs used to manage COVID-19. Access to health care may be difficult or limited, diagnosis of AL amyloidosis may be delayed with detrimental consequences and treatment administration may need modification. Both patients and treating physicians need to adapt in a new reality. Twit Text FOAVip Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32480420 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32480420 #FOAvip English Wikipedia <ref>{{Cite pmid|32480420}}</ref> Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic #MMPMID32480420 Kastritis E; Wechalekar A; Schonland S; Sanchorawala V; Merlini G; Palladini G; Minnema M; Roussel M; Jaccard A; Hegenbart U; Kumar S; Cibeira MT; Blade J; Dimopoulos MA Br J Haematol 2020[Aug]; 190 (3): 346-357 PMID32480420show ga The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated coronavirus disease 2019 (COVID-19) is primarily manifested as a respiratory tract infection, but may affect and cause complications in multiple organ systems (cardiovascular, gastrointestinal, kidneys, haematopoietic and immune systems), while no proven specific therapy exists. The challenges associated with COVID-19 are even greater for patients with light chain (AL) amyloidosis, a rare multisystemic disease affecting the heart, kidneys, liver, gastrointestinal and nervous system. Patients with AL amyloidosis may need to receive chemotherapy, which probably increases infection risk. Management of COVID-19 may be particularly challenging in patients with AL amyloidosis, who often present with cardiac dysfunction, nephrotic syndrome, neuropathy, low blood pressure and gastrointestinal symptoms. In addition, patients with AL amyloidosis may be more susceptible to toxicities of drugs used to manage COVID-19. Access to health care may be difficult or limited, diagnosis of AL amyloidosis may be delayed with detrimental consequences and treatment administration may need modification. Both patients and treating physicians need to adapt in a new reality. |Antiviral Agents/adverse effects/therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/drug therapy/epidemiology[MESH] |Health Services Accessibility[MESH] |Humans[MESH] |Immunoglobulin Light-chain Amyloidosis/*complications/drug therapy[MESH] |Immunologic Factors/adverse effects/therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/drug therapy/epidemiology[MESH]Challenges in the management of patients with systemic light chain (AL(epmc).pdf DeepDyve Pubget Overpricing